ConductScience.org, home

Paper3098544

Aldose reductase inhibitors and late complications of diabetes.

Benfield P. Drugs, 1986. Cited by 20 papers, by iCite.

Cite this record

ConductScience Library. Aldose reductase inhibitors and late complications of diabetes. Papers, record 3098544. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3098544

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Aldose reductase inhibitors and late complications of diabetes.
PubMed
Journal
Drugs
PubMed
Year
1986
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
20
iCite
Relative citation ratio, by iCite
0.72
iCite
Revised in PubMed
2026-10-11
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Benfield PP

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Aldehyde ReductaseMajor topic
Diabetic NeuropathiesMajor topic
Diabetic RetinopathyMajor topic
ImidazolesMajor topic
ImidazolidinesMajor topic
Sugar Alcohol DehydrogenasesMajor topic
Drug Hypersensitivity
Humans
Kinetics

Source PubMed

Download CSV of topics

References43

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
16427041Glomerular polyol accumulation in diabetes and its prevention by oral sorbinil.Diabetes1984https://conductscience.org/library/papers/6427041PubMed
26243893Pathology of autonomic neuropathy in diabetes mellitus.Ann Intern Med1980https://conductscience.org/library/papers/6243893PubMed
36808090Inhibition of human brain aldose reductase and hexonate dehydrogenase by alrestatin and sorbinil.J Neurochem1982https://conductscience.org/library/papers/6808090PubMed
46404681The effect of an aldose reductase inhibitor (Sorbinil) on the level of metabolites in lenses of diabetic rats.Diabetes1983https://conductscience.org/library/papers/6404681PubMed
56225686A controlled trial of sorbinil, an aldose reductase inhibitor, in chronic painful diabetic neuropathy.Diabetes1983https://conductscience.org/library/papers/6225686PubMed
66401351Aldose reductase inhibition improves nerve conduction velocity in diabetic patients.N Engl J Med1983https://conductscience.org/library/papers/6401351PubMed
76432615Clinical and neurophysiological studies with the aldose reductase inhibitor, sorbinil, in symptomatic diabetic neuropathy.Diabetologia1984https://conductscience.org/library/papers/6432615PubMed
83927328Reversal of stage-I sugar cataract by Sorbinil, an aldose reductase inhibitor.Pharmacology1985https://conductscience.org/library/papers/3927328PubMed
96785131Clinical trial of an aldose reductase inhibitor in diabetic neuropathy.Diabetes1981https://conductscience.org/library/papers/6785131PubMed
104073075Complications of diabetes. Prevalence, detection, current treatment, and prognosis.Am J Med1985https://conductscience.org/library/papers/4073075PubMed
112863103Metabolic disposition and pharmacokinetics of the aldose reductase inhibitor tolrestat in rats, dogs, and monkeys.Drug Metab Dispos1985https://conductscience.org/library/papers/2863103PubMed
124064465Effect of tolrestat on red blood cell sorbitol levels in patients with diabetes.Clin Pharmacol Ther1985https://conductscience.org/library/papers/4064465PubMed
133032499Aldose reductase inhibition, glomerular metabolism, and diabetic nephropathy.Diabet Med1985https://conductscience.org/library/papers/3032499PubMed
146407887Effect of a new aldose reductase inhibitor, (E)-3-carboxymethyl-5-[(2E)-methyl-3-phenylpropenylidene]rhodanine (ONO-2235) on peripheral nerve disorders in streptozotocin-diabetic rats.Diabetologia1983https://conductscience.org/library/papers/6407887PubMed
153920474Properties of ICI 128,436, a novel aldose reductase inhibitor, and its effects on diabetic complications in the rat.Metabolism1985https://conductscience.org/library/papers/3920474PubMed
163921093Screening for treatable diabetic retinopathy.Br Med J (Clin Res Ed)1985https://conductscience.org/library/papers/3921093PubMed
173930330Limited benefit of treatment of diabetic polyneuropathy with an aldose reductase inhibitor: a 24-week controlled trial.Diabetologia1985https://conductscience.org/library/papers/3930330PubMed
187356219Assessment of cardiovascular effects in diabetic autonomic neuropathy and prognostic implications.Ann Intern Med1980https://conductscience.org/library/papers/7356219PubMed
193922829Effects of a fructose-rich diet and the aldose reductase inhibitor, ONO-2235, on the development of diabetic neuropathy in streptozotocin-treated rats.Diabetologia1985https://conductscience.org/library/papers/3922829PubMed
203080763Diminished proteinuria in diabetes mellitus by sorbinil, an aldose reductase inhibitor.Pharmacology1986https://conductscience.org/library/papers/3080763PubMed

See all 43 referencesDownload CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 20 citations.

PMIDTitleJournalYearIn PapersSource
37805545Novel role for epalrestat: protecting against NLRP3 inflammasome-driven NASH by targeting aldose reductase.J Transl Med2023https://conductscience.org/library/papers/37805545PubMed
28535208Sodium glucose cotransporter 2 in mesangial cells and retinal pericytes and its implications for diabetic nephropathy and retinopathy.Glycobiology2017https://conductscience.org/library/papers/28535208PubMed
18984854Proteomic changes associated with diabetes in the BB-DP rat.Am J Physiol Endocrinol Metab2009https://conductscience.org/library/papers/18984854PubMed
11716759myo-Inositol oxygenase: molecular cloning and expression of a unique enzyme that oxidizes myo-inositol and D-chiro-inositol.Biochem J2001https://conductscience.org/library/papers/11716759PubMed
2721987Sorbitol metabolism in retina studied in vitro.Graefes Arch Clin Exp Ophthalmol1989https://conductscience.org/library/papers/2721987PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AKR1A110327PubTator's text mininghttps://conductscience.org/library/genes/10327NCBI Gene
AKR1B1231PubTator's text mininghttps://conductscience.org/library/genes/231NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3098544

GET https://conductscience.org/api/papers/v1/3098544/references?page=2